Goldman Sachs’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.43K Buy
+281
New +$5.94K ﹤0.01% 6418
2022
Q4
Sell
-4
Closed -$2K 6137
2022
Q3
$2K Sell
4
-94
-96% -$73.8K ﹤0.01% 6168
2022
Q2
$74K Buy
98
+62
+172% +$97.3K ﹤0.01% 5939
2022
Q1
$123K Sell
36
-45
-56% -$118K ﹤0.01% 6036
2021
Q4
$246K Buy
81
+19
+31% +$88.2K ﹤0.01% 5782
2021
Q3
$406K Sell
62
-2
-3% -$17.3K ﹤0.01% 5321
2021
Q2
$852K Buy
64
+29
+83% +$456K ﹤0.01% 4878
2021
Q1
$595K Buy
35
+16
+84% +$312K ﹤0.01% 4991
2020
Q4
$318K Sell
19
-56
-75% -$1.05M ﹤0.01% 4858
2020
Q3
$1.41M Sell
75
-52
-41% -$1.2M ﹤0.01% 3825
2020
Q2
$3.34M Sell
127
-47
-27% -$1.33M ﹤0.01% 3088
2020
Q1
$3.82M Buy
174
+147
+544% +$2.35M ﹤0.01% 2854
2019
Q4
$248K Sell
27
-14
-34% -$135K ﹤0.01% 4822
2019
Q3
$385K Buy
41
+30
+273% +$365K ﹤0.01% 4566
2019
Q2
$175K Sell
11
-10
-48% -$166K ﹤0.01% 4831
2019
Q1
$428K Sell
21
-7
-25% -$124K ﹤0.01% 4482
2018
Q4
$347K Buy
28
+4
+17% +$69.3K ﹤0.01% 4560
2018
Q3
$603K Buy
24
+11
+85% +$335K ﹤0.01% 4328
2018
Q2
$449K Buy
13
+5
+63% +$192K ﹤0.01% 4575
2018
Q1
$334K Buy
8
+3
+60% +$114K ﹤0.01% 4723
2017
Q4
$235K Buy
+5
New +$234K ﹤0.01% 5331

Other funds holding KALA

Goldman Sachs's KALA Position: Q1 2026 in Review

Goldman Sachs opened a new position in KALA BIO (KALA) in Q1 2026: 281 shares worth $2.43K. The stake represents ﹤0.01% of the portfolio and ranks #6418 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in KALA as recently as Q3 2022.

Goldman Sachs first reported a position in KALA in Q4 2017 and has held it in 21 quarters since. The position peaked at $3.82M in Q1 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Goldman Sachs held 281 shares of KALA BIO worth $2.43K as of Q1 2026.
  • KALA BIO was a new Goldman Sachs position in Q1 2026.
  • KALA BIO made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6418 holding.
  • Goldman Sachs first reported a position in KALA BIO in Q4 2017 and has held it in 21 quarters since.
  • Goldman Sachs's KALA BIO position peaked at $3.82M in Q1 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.